Evaluates biomarkers TL1A and CD40L in neurosarcoidosis, indicating their potential role in monitoring disease activity.
The objective of this study is to evaluate the presence of TL1A and the levels of CD40L in neurosarcoidosis patients and assess their relationship to disease activity.
No takes yet. Share an insight, caveat, or question.
Wyatt et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: